Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hologic (GB:0J5Q)
LSE:0J5Q
Holding GB:0J5Q?
Track your performance easily
0J5Q Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$64.69 - $83.85
Previous Close$81.42
Volume379.00
Average Volume (3M)3.41K
Market Cap
$18.69B
Enterprise Value$18.81B
Total Cash (Recent Filing)$2.44B
Total Debt (Recent Filing)$2.56B
Price to Earnings (P/E)27.8
Beta0.75
Next Earnings
Nov 04, 2024EPS Estimate
$1.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.93
Shares Outstanding232,271,906
10 Day Avg. Volume1,170
30 Day Avg. Volume3,413
Standard Deviation0.10
R-Squared0.12
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)3.85
Price to Sales (P/S)4.69
Price to Cash Flow (P/CF)11.50
P/FCF Ratio11.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.67
Enterprise Value/Gross Profit9.08
Enterprise Value/Ebitda78.97
Forecast
1Y Price Target
$86.56Price Target Upside6.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Hologic News
Bulls Say, Bears Say
Bulls Say
Acquisition And Product ExpansionHOLX announced an agreement to acquire privately-held Gynesonics for $350M, complementing its existing GYN Surgical business by expanding its product offering to include additional minimally invasive tools.
Growth In Breast Health SegmentThe upcoming Breast Health 3D mammography gantry cycle is expected to drive growth and support the stock's positive outlook, with strong 7% growth in this segment and easing chip supply constraints.
Strong Financial PerformanceHOLX's F3Q24 sales and EPS beat consensus, with organic ex-COVID sales growth improving to 5.8% Y/Y, driven by broad-based growth in non-COVID Diagnostics, Breast Health, and GYN Surgical.
Bears Say
Market ValuationShares are fairly valued as they trade in-line with peers, leading to a Neutral rating.
Revenue And Earnings ImpactA large portion of lost revenues are from time-based tenders, with no offsetting tailwind expected.
Supply Chain IssuesLingering supply chain issues in the non-core Skeletal Health segment could impact performance negatively.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.29% Insiders
29.98% Mutual Funds
1.63% Other Institutional Investors
41.45% Public Companies and
Individual Investors
0J5Q FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest share price was $64.69 and its highest was $83.84 in the past 12 months.
What is Hologic’s market cap?
Currently, no data Available
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Nov 04, 2024 which is in 16 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on Jul 29, 2024. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.017 by $0.043.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is $1.01.
How many shares outstanding does Hologic have?
Hologic has 232,271,910 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.06 in its last earnings report, beating expectations of $1.017. Following the earnings report the stock price went up 2.91%.
Which hedge fund is a major shareholder of Hologic?
Among the largest hedge funds holding Hologic’s share is Bridgewater Associates, LP. It holds Hologic’s shares valued at 24M.
---
Hologic Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$86.56 (6.31% Upside)
$86.56 (6.31% Upside)
Blogger Sentiment
Bullish
GB:0J5Q Sentiment 80%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $39.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.11%
12-Months-Change
Fundamentals
Return on Equity
13.85%
Trailing 12-Months
Asset Growth
-4.80%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.
---
0J5Q Company Deck
---
0J5Q Earnings Call
Q3 2024
0:00 / 0:00
---
0J5Q Revenue Breakdown
46.65% Diagnostics
35.55% Breast Health
14.99% GYN Surgical
2.81% Skeletal Health
---
0J5Q Stock 12 Month Forecast
Average Price Target
$86.56
▲(6.31% Upside)
Technical Analysis
Best Analysts Covering 0J5Q
1 Year
1 Year Success Rate
14/18 ratings generated profit
1 Year Average Return
+5.87%
reiterated a buy rating 13 days ago
Copying Puneet Souda's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +5.87% per trade.
---